A new monoterpenoid indole alkaloid, 15,20-dehydro-3-(2-oxopropyl) coronaridine (1), along with sixteen analogues (2-17) were isolated from the leaves of Catharanthus roseus cultivated in Yunnan. The new alkaloid was elucidated on the basis of extensive spectroscopic analysis, and the known alkaloids were identified by comparison with the reported spectroscopic data. Among them, alkaloid 16 was isolated from Catharanthus for the first time.
Alkaloid 1 was isolated as a white amorphous powder. Its molecular formula was deduced as C 24 H 28 N 2 O 3 based on 13 (t, C-5) and δ C 62.1 (d, C-21) revealed that C-3, C-21, and C-5 originated from carbons attached to N-4. Likewise, the HMBC cross-peaks of H-21/ C-2, δ C 54.8 (s, C-16), δ C 38.7 (t, C-17) and , δ C 55.9 (d, C-3); C-21 showed a double bond located at C-15/C-20 and a 3-(2-oxopropyl). These observations suggested that 1 possessed an ibogan-type monoterpenoid indole alkaloid carbon skeleton, similar to that of 3-(2-oxopropyl) coronaridine [3] . The differences between them were that a methylene and a methine in 3-(2-oxopropyl) coronaridine [3] were replaced by a double bond NOE correlations between H-21/δ H 3.71 (-COOCH 3 ), placed H-21 and COOCH 3 on the same face. Biogenetically, they were assigned with an -orientation, and H-14 with a -orientation of coronaridine derivatives isolated from Apocynaceae [16] . Moreover, NOE correlations between H-14 and H-3 suggested that H-14 and H-3 were on the same face, whereas the correlations between Me-18 and Me-24 positioned them on the opposite side (Figure 1 
Extraction and isolation:
The air-dried and powdered stems and branches of C. roseus (9.0 kg) were extracted with MeOH under reflux conditions, and the solvent was evaporated in vacuo. The residue was dissolved in 0.37% HCl (pH 2-3) and the solution was subsequently basified using 10% ammonia to pH 9-10. The basic solution was partitioned with EtOAc, affording a two-phase mixture. The EtOAc fraction (190 g) was subjected to CC over silica gel (Fr. A-F). Fr. A (6.5 g) was subjected to silica gel CC (light petroleum/acetone, 9:1-0:1, v/v) and recrystallization to yield 3 (700 mg), and 4 (26.5 mg). Fr. B (9.8 g) was eluted via silica gel CC under isocratic conditions (light petroleum/acetone, 7:1, v/v) to afford 1 (1.8 mg), 2 (5.6 mg), 8 (1.5 mg), 10 (4.7 mg), and 17 (10.0 mg). Compounds 14 (6.3 mg), 5 (10.3 mg), 9 (4.5 mg), and 11 (3.0 mg) were obtained from Fr. C (11.2 g) by silica gel CC with isocratic elution using light petroleum/acetone, 5:1. Fr. D (35.5 g) was subjected to silica gel CC (CHCl 3 /MeOH, 20:1-0:1) and further resolved by semi-HPLC to yield compounds 15 (2.4 mg), 12 (1.7 mg), 13 (159.6 mg), and 16 (30.7 mg). Fr. E (95.3 g) was chromatographed on a RP-18 column with MeOH/H 2 O (20:1-1:0, v/v) gradient system to give fractions E1-E8. Fractions E3 (6.3 g) and E5 (9.6 g) were separated on a Sephadex LH-20 column eluting with CHCl 3 /MeOH (1:1, v/v) and further by PTLC to yield 6 (10.8 mg), and 7 (4.8 mg).
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